Can methylene blue be repeated if methemoglobinemia persists after initial dose?

• A. Yes, may be repeated.
• B. No, single dose only.
• C. Repeat only if hematocrit is high.
• D. Repeat every 5 minutes.

Answer: (A)

Methylene blue can be repeated when methemoglobinemia remains after the initial dose. It works by acting as an artificial electron donor in the NADPH-dependent methemoglobin reductase pathway to convert ferric iron (Fe3+) back to ferrous iron (Fe2+) in hemoglobin, restoring oxygen-carrying capacity.

The usual course is 1–2 mg/kg given IV over a few minutes, with reassessment after about an hour. If methemoglobin is still high or the patient is symptomatic, a second dose may be given. However, there’s a limit to how much methylene blue you should give cumulatively (roughly 7 mg/kg total) because higher totals raise the risk of adverse effects, including hemolysis in G6PD deficiency and other toxicities. If G6PD deficiency is present or suspected, repeat dosing is avoided and alternative treatments (like ascorbic acid or exchange transfusion in severe cases) are considered. Also be mindful of drug interactions (e.g., SSRIs) that can complicate therapy.

So, yes, it may be repeated, but only within safe cumulative dosing and with reassessment and consideration of underlying G6PD status.